文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

结直肠癌肝转移肝切除术后预后因素随时间变化:1099例国际多中心分析

Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
PubMed 文献 · Ann Surg · 2019-01-01

该国际多中心队列纳入1099例可切除结直肠癌肝转移患者,采用条件生存(CS)分析评估遗传与临床病理因素对总生存影响的时变效应。结果显示BRAF突变在术后第一年主导预后(d=0.48),此后手术切缘与肝外病灶切除等手术相关因素决定预后(d≥0.5),传统临床病理因素持续但仅中度影响生存。

要点

  • BRAF突变状态在肝切除术后第一年主导预后,标准化差异d=0.48。
  • 术后一年后,手术切缘与肝外病灶切除等手术相关因素决定预后,d≥0.5。
  • 传统临床病理因素持续影响生存,但仅呈中度差异(0.3≤d<0.5)。

核心结论

  • 遗传、手术相关及临床病理因素对总生存和条件生存的影响随时间发生显著变化。
  • BRAF突变状态在术后第一年主导预后,而手术切缘阳性与肝外病灶切除在此后决定预后。

研究设计与样本

  • 国际多中心队列研究,纳入1099例可切除结直肠癌肝转移患者。
  • 采用条件生存分析,3年条件生存(CS3)按术后第x年计算为CS(x+3)/CS(x)。
  • 使用组间CS3率的标准化差异(d)评估预后因素效力随时间的变化。

主要发现

  • 按手术时总生存估计,BRAF与KRAS突变、R1切缘、切除肝外病灶、患者年龄、原发肿瘤淋巴结转移、肿瘤数目及癌胚抗原水平独立预测更差生存。
  • 采用CS3估计时,BRAF突变在第一年主导预后(d=0.48)。
  • 此后手术相关变量(手术切缘与切除肝外病灶)决定预后(d≥0.5)。
  • 传统临床病理因素持续影响生存,但仅呈中度差异(0.3≤d<0.5)。

关键数值与推荐

  • 标准化差异d<0.1表示组间差异非常小。
  • 0.1≤d<0.3表示差异小。
  • 0.3≤d<0.5表示差异中度。
  • d≥0.5表示差异强。

临床怎么用

  • 肝切除术后第一年应重点关注BRAF突变状态以评估预后。
  • 术后一年后应重点关注手术切缘与肝外病灶切除情况以评估预后。
  • 传统临床病理因素持续但仅中度影响生存,可用于全程风险分层参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the changing impact of genetic and clinicopathologic factors on conditional overall survival (CS) over time in patients with resectable colorectal liver metastasis. BACKGROUND: CS estimates account for the changing likelihood of survival over time and may reveal the changing impact of prognostic factors as time accrues from the date of surgery. METHODS: CS analysis was performed in 1099 patients of an international, multi-institutional cohort. Three-year CS (CS3) estimates at the "xth" year after surgery were calculated as follows: CS3 = CS (x + 3)/CS (x). The standardized difference (d) between CS3 rates was used to estimate the changing prognostic power of selected variables over time. A d < 0.1 indicated very small differences between groups, 0.1 ≤ d < 0.3 indicated small differences, 0.3 ≤ d < 0.5 indicated moderate differences, and d ≥ 0.5 indicated strong differences. RESULTS: According to OS estimates calculated at the time of surgery, the presence of BRAF and KRAS mutations, R1 margin status, resected extrahepatic disease, patient age, primary tumor lymph node metastasis, tumor number, and carcinoembryonic antigen levels independently predicted worse survival. However, when temporal changes in the prognostic impact of these variables were considered using CS3 estimates, BRAF mutation dominated prognosis during the first year (d = 0.48), whereas surgeon-related variables (ie, surgical margin and resected extrahepatic disease) determined prognosis thereafter (d ≥ 0.5). Traditional clinicopathologic factors affected survival constantly, but only to a moderate degree (0.3 ≤ d < 0.5). CONCLUSIONS: The impact of genetic, surgery-related, and clinicopathologic factors on OS and CS3 changed dramatically over time. Specifically, BRAF mutation status dominated prognosis in the first year, whereas positive surgical margins and resected extrahepatic disease determined prognosis thereafter.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Margonis GA, Buettner S, Andreatos N, et al. Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients. Ann Surg. 2019. PMID: 31082912. doi:10.1097/SLA.0000000000002664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。